About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Second Propedeutic Department of Internal Medicine
›
top-articles
Second Propedeutic Department of Internal Medicine
433
(top 1%)
papers
10.4K
(top 1%)
citations
51
(top 1%)
h
-index
92
(top 1%)
g
-index
510
all documents
11.7K
doc citations
2.4K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Lancet, The
2010
594
2
Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention
Current Medical Research and Opinion
2002
510
3
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study
Lancet, The
2008
450
4
Non-alcoholic fatty liver disease and dyslipidemia: An update
Metabolism: Clinical and Experimental
2016
363
5
Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Archives of Medical Science
2015
311
6
Atorvastatin and Micronized Fenofibrate Alone and in Combination in Type 2 Diabetes With Combined Hyperlipidemia
Diabetes Care
2002
253
7
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the greek atorvastatin and coronary-heart-disease evaluation (GREACE) study
American Journal of Kidney Diseases
2004
224
8
Leptin, cardiovascular diseases and type 2 diabetes mellitus
Acta Pharmacologica Sinica
2018
197
9
Diabetes and lipid metabolism
Hormones
2018
192
10
Gonadal dysfunction in systemic diseases
European Journal of Endocrinology
2005
187
11
Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis
Review of Diabetic Studies
2015
169
12
Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?
Osteoporosis International
2009
146
13
Pleiotropic Effects of Statins - Clinical Evidence
Current Pharmaceutical Design
2009
144
14
Pharmacotherapy of type 2 diabetes: An update
Metabolism: Clinical and Experimental
2018
144
15
The prevalence of the metabolic syndrome in Greece: The MetS-Greece Multicentre Study
Diabetes, Obesity and Metabolism
2005
134
16
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials
European Heart Journal
2015
126
17
Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis
Blood
2010
124
18
Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control
Diabetes, Obesity and Metabolism
2011
123
19
Serum Uric Acid as an Independent Predictor of Early Death After Acute Stroke
Circulation Journal
2007
119
20
Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Expert Opinion on Drug Safety
2015
117
21
Health Benefits of the Mediterranean Diet
Angiology
2015
117
22
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism
Expert Opinion on Pharmacotherapy
2008
115
23
Pheochromocytoma: an update on genetics and management
Endocrine-Related Cancer
2007
114
24
The Role of Fibrate Treatment in Dyslipidemia: An Overview
Current Pharmaceutical Design
2013
104
25
Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
Current Drug Targets
2010
100
26
Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance
Journal of Diabetes and Its Complications
2018
97
27
Sodium–glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways
Journal of Cellular Physiology
2019
97
28
Contrast-Induced Nephropathy
Angiology
2015
96
29
Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population
Current Medical Research and Opinion
2010
93
30
Regulation of PCSK9 by nutraceuticals
Pharmacological Research
2017
89
31
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
Metabolism: Clinical and Experimental
2020
88
32
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
Metabolism: Clinical and Experimental
2013
87
33
Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys
Drug Discovery Today
2019
87
34
Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
Current Vascular Pharmacology
2018
87
35
Obesity and cardiovascular risk
Journal of Hypertension
2018
86
36
Do we need to consider inflammatory markers when we treat atherosclerotic disease?
Atherosclerosis
2008
79
37
Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness
Journal of the American Society of Hypertension
2014
75
38
Cardiovascular benefits of bariatric surgery in morbidly obese patients
Obesity Reviews
2011
72
39
Semaglutide as a promising antiobesity drug
Obesity Reviews
2019
71
40
Epicardial fat and vascular risk
Current Opinion in Cardiology
2013
70
41
Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk
Current Vascular Pharmacology
2018
69
42
Angiotensin II reactivation and aldosterone escape phenomena in renin–angiotensin–aldosterone system blockade: is oral renin inhibition the solution?
Expert Opinion on Pharmacotherapy
2007
68
43
Effectiveness of Ezetimibe Alone or in Combination With Twice a Week Atorvastatin (10 mg) for Statin Intolerant High-Risk Patients
American Journal of Cardiology
2008
68
44
Adrenal incidentaloma: a diagnostic challenge
Hormones
2009
68
45
Hyperuricaemia
Journal of Cardiovascular Medicine
2013
66
46
MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment
Metabolism: Clinical and Experimental
2018
65
47
Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Drugs
2018
64
48
The pharmacokinetic considerations and adverse effects of DDP-4 inhibitors
Expert Opinion on Drug Metabolism and Toxicology
2014
59
49
The link between insulin resistance parameters and serum uric acid is mediated by adiposity
Atherosclerosis
2018
59
50
Bone mineral density in men and children with haemophilia A and B: a systematic review and meta-analysis
Osteoporosis International
2014
58
site/software ©
exaly
; All materials licenced under
CC by-SA
.